Signaturefd, LLC Castle Biosciences Inc Transaction History

Signaturefd, LLC

  • $5.2 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023
SELL
$13.28 - $20.3 $424 - $649
-32 Reduced 0.11%
28,358 $478,000
Q2 2023

Aug 01, 2023
BUY
$11.66 - $26.0 $104,730 - $233,532
8,982 Added 46.28%
28,390 $389,000
Q1 2023

Apr 28, 2023
BUY
$19.47 - $28.49 $214 - $313
11 Added 0.06%
19,408 $440,000
Q2 2022

Aug 10, 2022
BUY
$16.0 - $45.99 $121,472 - $349,156
7,592 Added 64.31%
19,397 $426,000
Q1 2022

May 02, 2022
SELL
$33.17 - $46.98 $252,423 - $357,517
-7,610 Reduced 39.2%
11,805 $530,000
Q4 2021

Jan 25, 2022
BUY
$39.06 - $67.58 $1,249 - $2,162
32 Added 0.17%
19,415 $832,000
Q3 2021

Oct 28, 2021
BUY
$60.13 - $77.6 $601 - $776
10 Added 0.05%
19,383 $1.29 Million
Q2 2021

Jul 26, 2021
BUY
$50.07 - $76.78 $400 - $614
8 Added 0.04%
19,373 $1.42 Million
Q1 2021

Apr 30, 2021
BUY
$58.92 - $97.33 $14,140 - $23,359
240 Added 1.25%
19,365 $1.33 Million
Q4 2020

Feb 11, 2021
SELL
$43.6 - $73.05 $566,800 - $949,650
-13,000 Reduced 40.47%
19,125 $1.28 Million
Q2 2020

Jul 30, 2020
BUY
$27.28 - $43.01 $163,489 - $257,758
5,993 Added 22.93%
32,125 $1.21 Million
Q1 2020

Apr 23, 2020
BUY
$23.08 - $35.53 $230,799 - $355,300
10,000 Added 61.99%
26,132 $779,000
Q4 2019

Feb 05, 2020
BUY
$15.74 - $35.04 $253,917 - $565,265
16,132 New
16,132 $554,000

Others Institutions Holding CSTL

# of Institutions
201
Shares Held
24.5M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $752M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email